LEADER 10748nam 2200517 450 001 9910483853403321 005 20220715162453.0 010 $a981-336-284-7 035 $a(CKB)4100000011912096 035 $a(MiAaPQ)EBC6578044 035 $a(Au-PeEL)EBL6578044 035 $a(OCoLC)1249474777 035 $a(PPN)255294816 035 $a(EXLCZ)994100000011912096 100 $a20211211d2021 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aEssentials of rhinology /$fHitesh Verma, Alok Thakar, editors 210 1$aGateway East, Singapore :$cSpringer,$d[2021] 210 4$d©2021 215 $a1 online resource (350 pages) 311 $a981-336-283-9 327 $aIntro -- Foreword -- Preface -- Contents -- About the Editors -- List of Contributors -- 1: Endoscopic Anatomy and Surgery -- 1.1 Part A: Anatomy of Nasal Cavity and Paranasal Sinuses -- 1.1.1 Ethmoid Cells -- 1.1.2 Frontal Sinus -- 1.1.3 Maxillary Sinus -- 1.1.4 Anterior Ethmoid Artery -- 1.1.5 Sphenopalatine Artery -- 1.1.6 Cribriform Plate -- 1.1.7 Sphenoid Sinus -- 1.1.8 Optic Nerve Relationship with Paranasal Sinuses -- 1.2 Part B: Local Anesthesia and Regional Blocks in Nasal Surgery -- 1.3 Part C: General Anesthesia -- 1.3.1 Preoperative Concerns -- 1.3.2 Anesthesia Technique -- 1.3.3 Hypotensive Anesthesia -- 1.3.4 Acute Normovolemic Hemodilution -- 1.3.5 Juvenile Nasopharyngeal Angiofibroma with Intracranial Extension -- 1.3.6 Emergence from Anesthesia -- 1.3.7 Postoperative Concerns -- 1.3.8 Emergency Surgical Intervention -- 1.4 Part D: FESS -- 1.4.1 Diagnostic Endoscopy -- 1.4.2 FESS Techniques and Steps -- 1.4.3 NASAL POLYP and FESS -- 1.4.4 AFRS and FESS -- 1.4.5 ESS in Pediatric Age Group -- 1.4.6 Balloon Sinuplasty -- 1.4.7 Conclusion -- 1.5 Part E: Packing Materials for Nose and Paranasal Sinuses -- 1.5.1 Uses of Nasal Packing -- 1.5.2 Types of Nasal Packing Material -- 1.5.3 Non-Absorbable Nasal Packs -- 1.5.4 Absorbable Nasal Packs -- References -- 2: Rhinoplasty Anatomy and Procedures -- 2.1 Part A: External Nasal Anatomy, Aesthetics and Photography -- 2.1.1 Photography and Analysis -- 2.2 Part B: Open and Close Rhinoplasty and Tip Plasty -- 2.2.1 Introduction -- 2.2.2 Approaches -- 2.2.3 Tip Defining Procedures -- 2.2.4 Management of the Overprojecting Tip -- 2.2.5 The Under-Projected Nasal Tip -- 2.2.6 The Broad Nasal Tip -- 2.2.7 Complications -- 2.3 Part C: Nasal Dorsum Correction and Material for Rhinoplasty -- 2.3.1 Post-Operative Management. 327 $a2.3.2 Materials for Reconstruction in Rhinoplasty -- References -- 3: Nasal Physiology and Sinusitis -- 3.1 Part A: Physiology of Nose and Paranasal Sinuses -- 3.1.1 Introduction -- 3.1.2 Nasal Secretions and Mucociliary Drainage -- 3.1.2.1 Nasal Mucosal Lining -- 3.1.2.2 Contents of Nasal Secretions -- 3.1.2.3 Mucociliary Drainage Pattern -- 3.1.2.4 Tests for Mucociliary Clearance -- 3.1.3 Nasal Breathing -- 3.1.3.1 Measurement of Nasal Breathing -- 3.1.3.2 Important Objective Tests of Nasal Breathing -- 3.1.3.3 References Values for Normal Adults -- 3.2 Part B: Olfactory Nerve and Olfactory Dysfunctions -- 3.2.1 Anatomy of Olfactory Nerve -- 3.2.2 Blood Supply of Olfactory Nerve -- 3.2.3 Smell Disorders -- 3.2.3.1 Epidemiology -- 3.2.4 Management of Smell Disorders -- 3.2.4.1 Investigations -- 3.2.4.2 Treatment Options -- 3.2.5 Bioelectronic Nose -- 3.2.6 Applications of Bioelectronic Nose -- 3.3 Part C-Acute and Chronic Rhinosinusitis -- 3.3.1 Summary -- 3.3.2 Introduction -- 3.3.3 Pathophysiology -- 3.3.4 Diagnostic Work Up -- 3.3.5 Radiological Staging -- 3.3.6 Differential Diagnosis -- 3.3.7 Complications -- 3.3.8 Treatment -- 3.3.8.1 Antibiotics -- 3.3.8.2 Nasal Sprays and Irrigation -- 3.3.8.3 Oral Steroids and Anti-Histaminics -- 3.3.9 Surgery -- 3.4 Part D: Frontal Sinusitis -- 3.4.1 Summary -- 3.4.2 Introduction -- 3.4.3 Pathophysiology -- 3.4.4 Preoperative Workup -- 3.4.4.1 Surgical Approaches -- 3.4.4.2 Open Approaches -- 3.5 Part E: Complications of Sinusitis -- 3.5.1 Summary -- 3.5.2 Introduction -- 3.5.3 Conclusion -- 3.6 Part F: Allergic Rhinitis -- 3.6.1 Introduction -- 3.6.2 Clinical Manifestations and Differential Diagnosis -- 3.6.3 Cascading Inflammation of AR Causing Complications and Comorbidities -- 3.6.4 Management of AR: Therapeutic Options (Fig. 3.18). 327 $a3.6.5 Leukotriene Receptor Antagonists -- 3.6.6 Difficult-to-Treat AR -- 3.6.7 Allergen Immunotherapy (AIT) -- 3.6.8 Allergens and Non-Allergic Triggers -- 3.6.9 SLIT as Food Allergen Immunotherapy -- 3.6.10 Allergen Avoidance, Complimentary Lifestyle, and Prevention -- 3.6.10.1 Allergen Avoidance: -- 3.6.10.2 Complimentary Lifestyle -- 3.6.10.3 Prevention of Allergy: -- 3.7 Part G: Vasomotor Rhinitis -- 3.7.1 Introduction -- 3.7.2 Pathogenesis -- 3.7.3 Clinical Features -- 3.7.4 Diagnosis -- 3.7.5 Treatment -- 3.8 Part H: Non-Invasive Fungal Sinusitis -- 3.8.1 Introduction -- 3.9 Part I: Invasive Fungal Sinusitis -- 3.9.1 Clinical Presentations -- 3.9.2 Diagnosis -- 3.9.3 Imaging -- 3.9.4 Pathology -- 3.9.5 Treatment -- 3.9.6 Outcome and Follow-Up -- References -- 4: Granulomatous Disease and Faciomaxillary Trauma -- 4.1 Part A: Granulomatous Disease of the Nose and Paranasal Sinuses -- 4.1.1 Introduction -- 4.1.2 Other Granulomatous Pathology -- 4.2 Part B: Atrophic Rhinitis -- 4.2.1 Pathology -- 4.2.1.1 Clinical Features -- 4.2.1.2 Investigations -- 4.2.2 Management Aim -- 4.2.3 Surgical Management -- 4.3 Part C: Maxillofacial Trauma -- 4.3.1 Introduction -- 4.3.1.1 Assessment of a Maxillofacial Trauma Patient -- 4.3.2 Imaging -- 4.3.3 Timing of Surgical Intervention -- 4.3.4 Airway Management During Surgery -- 4.3.4.1 Mandibular Fractures -- 4.3.5 Management of Nasal Bone Fractures -- 4.3.6 Zygomatic Fractures -- 4.3.7 Fractures of Midface -- 4.3.8 Orbital Fractures -- 4.3.9 Postoperative Care -- References -- 5: Diagnostic Method and Instrumentation in Rhinology -- 5.1 Part A: Diagnosis of Fungal Infections of Nose and Paranasal Sinuses -- 5.1.1 Introduction -- 5.1.2 Diagnosis of Invasive FRS -- 5.1.3 Specimens -- 5.1.4 Sample Transport -- 5.1.5 Sample Processing. 327 $a5.1.6 Culture and Antifungal Susceptibility Testing (AFST) -- 5.1.7 Serologic Tests -- 5.1.7.1 Beta-1,3,-Glucan (BDG) -- 5.1.7.2 Galactomannan Antigen Detection -- 5.1.7.3 Aspergillus-Specific Lateral Flow Device (LFD) -- 5.1.7.4 Polymerase Chain Reaction (PCR) -- 5.2 Part B: Intervention Radiology for Rhinology -- 5.2.1 Pre-Requisites -- 5.2.2 Image-Guided Sampling -- 5.2.3 DSA Assessment of Vascularity and Collateralization -- 5.2.4 DSA Embolization in Trauma Setting -- 5.2.5 DSA Embolization in Epistaxis -- 5.2.6 DSA Embolization in Tumors -- 5.2.7 DSA Embolization in AVMs -- 5.2.8 Sclerotherapy for Sinonasal Low-Flow Malformations -- 5.2.9 Complications -- 5.3 Part C: Nuclear Medicine Perspective -- 5.3.1 Introduction -- 5.3.1.1 Skull Base Osteomyelitis -- Three Phase Bone Scintigraphy -- 18F FDG PET/CT -- WBC Labeled Imaging -- Tumor Imaging -- 5.4 Part D: Bacteriology and Virology -- 5.4.1 Introduction -- 5.4.1.1 Bacteriology of Nose and PNS -- 5.4.2 Staining Procedures -- 5.4.3 Culture Media Are Required to Isolate the Bacteria from the Clinical Specimens -- 5.4.3.1 Storage of Media -- 5.4.4 Nucleic Acid Amplification Techniques (NAAT) -- 5.4.5 Antibiotic Sensitivity, Resistance, and Prevention -- 5.4.6 Viruses in ENT -- 5.4.7 Laboratory Diagnosis of Viral Diseases -- 5.4.7.1 Detection Methods for Viruses -- 5.5 Part E: Advanced Instruments in Rhinology -- References -- 6: Tumours of Nose and Paranasal Sinuses -- 6.1 Part A: Benign Lesions of Nose and Paranasal Sinuses -- 6.1.1 Introduction -- 6.1.2 Clinical Presentation -- 6.1.3 Benign Tumours of Epithelial Origin Sinonasal Papilloma -- 6.1.3.1 Inverted Papilloma (Shneiderian Papilloma, Inverting Type) -- 6.1.4 Clinical Presentation -- 6.1.5 Schneiderian Papilloma (Oncocytic Type) -- 6.1.6 Schneiderian Papilloma (Exophytic Type). 327 $a6.1.7 Salivary Gland Adenoma -- 6.1.8 Benign Tumours of Bony and Cartilaginous Origin -- 6.1.8.1 Osteoma -- 6.1.8.2 Chondroma -- 6.1.9 Fibroosseus Lesion -- 6.1.9.1 Fibrous Dysplasia -- 6.1.9.2 Ossifying Fibroma -- 6.1.10 Benign Vascular Tumours -- 6.1.10.1 Lobular Capillary Haemangioma (Pyogenic Granuloma) -- 6.1.11 Other Rare Lesions -- 6.2 Part B: Angiofibroma, Its Medical and Surgical Management -- 6.2.1 Extensions -- 6.2.1.1 Staging System -- 6.2.1.2 Histopathology -- 6.2.1.3 Treatment -- 6.3 Part C: Cancer of Nose and Paranasal Sinuses -- 6.3.1 Aetiology -- 6.3.2 Patterns of Tumour Spread -- 6.3.3 Clinical Features -- 6.3.4 Histopathology -- 6.3.5 Stage with Description -- 6.3.5.1 T Staging -- 6.4 Part D: Nasopharyngeal Carcinoma -- 6.4.1 Summary -- 6.4.2 Anatomy of Nasopharynx -- 6.4.3 Benign Tumours -- 6.4.4 Nasopharyngeal Carcinoma -- 6.5 Part E: Pathology of Lesions of the Nose and Paranasal Sinuses -- 6.5.1 Sinonasal Neoplasms -- 6.5.2 Carcinomas -- 6.5.2.1 Squamous Cell Carcinoma (SCC) -- 6.5.2.2 SMARCB1-Deficient Sinonasal Carcinoma -- 6.5.2.3 NUT Carcinoma -- 6.5.2.4 Adenocarcinoma -- 6.5.2.5 Neuroendocrine Carcinomas (NECs) -- 6.5.2.6 Sinonasal Undifferentiated Carcinoma (SNUC) -- 6.5.3 Sinonasal Papillomas -- 6.5.4 Mesenchymal Neoplasms -- 6.5.4.1 Rhabdomyosarcoma (RMS) -- 6.5.4.2 Schwannoma -- 6.5.4.3 Nasopharyngeal Angiofibroma -- 6.5.5 Other Malignant Neoplasms -- 6.5.5.1 Olfactory Neuroblastoma -- 6.5.5.2 Sinonasal Teratocarcinosarcoma -- 6.5.5.3 Extranodal NK/T Cell Lymphoma, Nasal Type -- 6.5.6 Fibroosseous Lesions -- 6.5.6.1 Ossifying Fibroma -- 6.5.6.2 Fibrous Dysplasia -- 6.5.7 Nasal Polyps -- 6.5.7.1 Inflammatory Nasal Polyp -- 6.5.7.2 Antrochoanal Polyp -- 6.5.7.3 Allergic Nasal Polyp -- References -- 7: Extended Procedures -- 7.1 Part A: Extended Endoscopic Approach. 327 $a7.1.1 Contraindications of EEAs. 606 $aMalalties del nas$2thub 606 $aNose$xDiseases 608 $aLlibres electrònics$2thub 615 7$aMalalties del nas 615 0$aNose$xDiseases. 676 $a616.2 702 $aVerma$b Hitesh 702 $aThakar$b Alok 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910483853403321 996 $aEssentials of rhinology$92557849 997 $aUNINA